Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents-Reference-Cited by-同舟云学术

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents

Published:2015-05 Issue:2 Volume:108 Page:350-359
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Home Philip D.,Dain Marie-Paule,Freemantle Nick,Kawamori Ryuzo,Pfohl Martin,Brette Sandrine,Pilorget Valérie,Scherbaum Werner A.,Vespasiani Giacomo,Vincent Maya,Balkau Beverley

Funder

Sanofi

Medtronic

Pfizer

Boehringer Ingelheim

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. International Diabetes Federation: global guideline for type 2 diabetes;Diabetes Res Clin Pract,2014

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

3. NICE. Blood-glucose-lowering therapy for type 2 diabetes. National Institute for Health and Care Excellence. http://pathways.nice.org.uk/pathways/diabetes#path=view%3A/pathways/diabetes/blood-glucose-lowering-therapy-for-type-2-diabetes.xml&content=view-node%3Anodes-starting-insulin-particularly-if-hyperglycaemia-is-marked. [accessed 12.06.13].

4. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study;Home;Diabetes Res Clin Pract,2011

5. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes;Holman;N Engl J Med,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistently High Glycated Hemoglobin in a Subgroup of Type 2 Diabetic Patients Who Failed Usual Oral Antihyperglycemics and Insulin in Côte d’Ivoire;Advances in Biological Chemistry;2023

2. Effects of different regimens of insulin on body mass index commonly used in type 2 diabetes mellitus;Bangladesh Journal of Endocrinology and Metabolism;2022

3. 'Real-world' clinical trials in diabetes care: meaningful or meaningless?;British Journal of Diabetes;2021-12-06

4. Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis;Diabetes, Obesity and Metabolism;2020-09-03

5. Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting;Diabetes, Obesity and Metabolism;2020-01-24